Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kate Barclay Consulting is a UK-based private consulting company providing scientific and industry advisory services in the life sciences sector. The business appears to operate as a small specialist consultancy rather than a drug developer, with public references describing Kate Barclay as a life sciences industry leader and scientific consultant. Available records indicate the company is active and incorporated in 2016 in the United Kingdom. There is no evidence that the company has a therapeutic pipeline, proprietary drug platform, or in-house clinical programs. Its focus appears to be strategic consulting, leadership, and advisory work across biotech, pharmaceutical, and technical skills/workforce initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kate Barclay Consulting.